Qulipta 00074-7094-30
Generic: Atogepant
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 30, 2021
- Listing Expires
- December 31, 2027
- Application
- NDA215206
Need to source Qulipta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atogepant | 60 mg/1 |
Drug Class
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
Selected Package
00074-7094-30Selected30 TABLET in 1 BOTTLE (0074-7094-30)
Other packages for this product(2)
4 TABLET in 1 BOTTLE (0074-7094-04)
4 TABLET in 1 BOTTLE (0074-7094-70)